ZA913910B - Use of baclofen for obtaining medicaments for the treatment of angina pectoris - Google Patents

Use of baclofen for obtaining medicaments for the treatment of angina pectoris

Info

Publication number
ZA913910B
ZA913910B ZA913910A ZA913910A ZA913910B ZA 913910 B ZA913910 B ZA 913910B ZA 913910 A ZA913910 A ZA 913910A ZA 913910 A ZA913910 A ZA 913910A ZA 913910 B ZA913910 B ZA 913910B
Authority
ZA
South Africa
Prior art keywords
baclofen
treatment
angina pectoris
obtaining medicaments
medicaments
Prior art date
Application number
ZA913910A
Other languages
English (en)
Inventor
Pascal-Pierre Bousquet
Bousquet Pascal-Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA913910B publication Critical patent/ZA913910B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA913910A 1990-05-23 1991-05-23 Use of baclofen for obtaining medicaments for the treatment of angina pectoris ZA913910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006437A FR2662354B1 (fr) 1990-05-23 1990-05-23 Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.

Publications (1)

Publication Number Publication Date
ZA913910B true ZA913910B (en) 1992-02-26

Family

ID=9396882

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913910A ZA913910B (en) 1990-05-23 1991-05-23 Use of baclofen for obtaining medicaments for the treatment of angina pectoris

Country Status (15)

Country Link
US (1) US5149713A (pt)
EP (1) EP0458699B1 (pt)
JP (1) JPH0717502B2 (pt)
AT (1) ATE116848T1 (pt)
AU (1) AU635418B2 (pt)
CA (1) CA2043033C (pt)
DE (1) DE69106586T2 (pt)
DK (1) DK0458699T3 (pt)
ES (1) ES2069843T3 (pt)
FR (1) FR2662354B1 (pt)
GR (1) GR3015513T3 (pt)
IE (1) IE65575B1 (pt)
OA (1) OA09498A (pt)
PT (1) PT97743B (pt)
ZA (1) ZA913910B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045791A2 (en) 2000-10-26 2002-06-13 Medtronic, Inc. Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac comditions
US20070191895A1 (en) * 2001-04-20 2007-08-16 Foreman Robert D Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure
EP1395330A1 (en) * 2001-04-20 2004-03-10 The Board of Regents for the University of Oklahoma Cardiac neuromodulation and methods of using same
WO2002096512A1 (en) 2001-05-29 2002-12-05 Medtronic, Inc. Closed-loop neuromodulation for prevention and treatment of cardiac conditions
US7657482B1 (en) * 2002-07-15 2010-02-02 Paymentech, L.P. System and apparatus for transaction fraud processing
US7824697B2 (en) * 2004-07-12 2010-11-02 Board Of Regents, The University Of Texas System High concentration baclofen preparations
CA2721135A1 (en) 2007-06-13 2008-12-24 Wayne State University Board Of Governors A zwitterion solution for low-volume therapeutic delivery
WO2008157288A2 (en) 2007-06-13 2008-12-24 Wayne State University Board Of Governors A baclofen solution for low-volume therapeutic delivery
US20150258279A1 (en) 2008-03-18 2015-09-17 Mallinckrodt Llc Intrathecal baclofen pharmaceutical dosage forms and related delivery system
US8969414B2 (en) 2009-02-06 2015-03-03 Mallinckrodt Llc Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
EP2211978A1 (en) 2008-04-30 2010-08-04 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8005539B2 (en) * 2008-10-31 2011-08-23 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9775987B2 (en) 2008-10-31 2017-10-03 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
WO2010051486A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US8611996B2 (en) 2008-10-31 2013-12-17 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8260412B2 (en) 2008-10-31 2012-09-04 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US9192769B2 (en) * 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8532779B2 (en) * 2008-10-31 2013-09-10 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8249708B2 (en) * 2008-10-31 2012-08-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8774918B2 (en) * 2008-10-31 2014-07-08 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9026206B2 (en) * 2008-10-31 2015-05-05 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8688210B2 (en) * 2008-10-31 2014-04-01 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8452394B2 (en) 2008-10-31 2013-05-28 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US9597505B2 (en) * 2008-10-31 2017-03-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9622997B2 (en) 2012-06-01 2017-04-18 Lynn Health Science Institute, Inc. Methods for treating insomnia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) * 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
GB1547609A (en) * 1975-04-28 1979-06-20 Nelson Res & Dev Potentiated hypotensive composition
US4084000A (en) * 1975-07-16 1978-04-11 Nelson Research And Development Company Method of treating schizophrenia
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
AU7619291A (en) 1991-11-28
PT97743B (pt) 1998-10-30
JPH0717502B2 (ja) 1995-03-01
US5149713A (en) 1992-09-22
FR2662354B1 (fr) 1994-10-07
GR3015513T3 (en) 1995-06-30
DE69106586T2 (de) 1995-07-06
FR2662354A1 (fr) 1991-11-29
DE69106586D1 (de) 1995-02-23
AU635418B2 (en) 1993-03-18
ATE116848T1 (de) 1995-01-15
JPH04226914A (ja) 1992-08-17
OA09498A (fr) 1992-11-15
PT97743A (pt) 1992-02-28
DK0458699T3 (da) 1995-06-12
IE911742A1 (en) 1991-12-04
EP0458699A3 (en) 1992-03-04
CA2043033A1 (fr) 1991-11-24
CA2043033C (fr) 1998-09-29
EP0458699A2 (fr) 1991-11-27
IE65575B1 (en) 1995-11-01
EP0458699B1 (fr) 1995-01-11
ES2069843T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
TW206916B (pt)
IT1229845B (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
AR240403A1 (es) Procedimiento para la esterilizacion de articulos utilizando vapor de peroxido de hidrogeno
DE3779053D1 (pt)
ES2014392A4 (es) Procedimiento para la fabricacion de peroxido de hidrogeno.
FR2651435B1 (pt)
DK0582897T3 (da) Arbejdsområdelampe til den medicinske, især tandmedicinske praksis
DK0582900T3 (da) Arbejdsområdelampe til den medicinske, især tandmedicinske praksis
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
GB8716685D0 (en) Vapour source assembly
IL105285A0 (en) Compositions for the treatment of diabetes
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
GR3005231T3 (pt)
DE3776488D1 (pt)
NO884635L (no) Fremgangsmaate for behandling av voerter.
HU9502697D0 (en) Drogs for the treatment of retrovirus infections
ITMI930983A0 (it) Procedimento per la preparazione del (+)-3-idrossi-17-metilmorfinano
AU6349990A (en) Utilization of anticomplements for the treatment of periodontosis
NO885048D0 (no) Fremgangsmÿte ved gassbehandling.
ITMI932004A1 (it) Procedimento per la preparazione del 7-isopropossiisoflavone
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione
BG51950B2 (en) Biopreparation for the treatment of chemical skin burns
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.